Andy J. Minn

Active 1995–2025

64
Papers
30,128
Citations
54
h-index
64
i10-index

Citations

Citations per year for Andy J. Minn1926: 2 citations1980: 1 citations1993: 1 citations1995: 5 citations1996: 49 citations1997: 116 citations1998: 166 citations1999: 162 citations2000: 173 citations2001: 119 citations2002: 122 citations2003: 109 citations2004: 95 citations2005: 96 citations2006: 125 citations2007: 149 citations2008: 166 citations2009: 191 citations2010: 191 citations2011: 223 citations2012: 191 citations2013: 210 citations2014: 194 citations2015: 276 citations2016: 447 citations2017: 526 citations2018: 612 citations2019: 1,442 citations2020: 1,662 citations2021: 1,734 citations2022: 1,289 citations2023: 1,037 citations2024: 1,395 citations2025: 799 citations2026: 32 citations1927–1979: no citations, so these years are not shown1981–1992: no citations, so these years are not shown1994: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 5,499 citing papers, 30.8% of this breakdownChina: 3,073 citing papers, 17.2% of this breakdownGermany: 847 citing papers, 4.7% of this breakdownUnited Kingdom: 844 citing papers, 4.7% of this breakdownItaly: 639 citing papers, 3.6% of this breakdownFrance: 587 citing papers, 3.3% of this breakdownJapan: 566 citing papers, 3.2% of this breakdownAustralia: 530 citing papers, 3% of this breakdownCanada: 498 citing papers, 2.8% of this breakdownSpain: 409 citing papers, 2.3% of this breakdownSwitzerland: 387 citing papers, 2.2% of this breakdownNetherlands: 371 citing papers, 2.1% of this breakdown
0%30.8%Other 20.1%

Fields

  • Biochemistry, Genetics and Molecular Biology48.5%
  • Medicine33.6%
  • Immunology and Microbiology12.7%
  • Engineering1.7%
  • Computer Science0.8%
  • Neuroscience0.6%
  • Other2.1%

Topics

  • Extracellular vesicles in disease7.2%
  • Cancer Immunotherapy and Biomarkers5.3%
  • MicroRNA in disease regulation5%
  • Immunotherapy and Immune Responses3.6%
  • Immune Cell Function and Interaction2.8%
  • Cancer Cells and Metastasis2.4%
  • Other73.7%

Coauthors

All papers

Open in search
  1. Tumour exosome integrins determine organotropic metastasis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Knut Jørgen Labori, Elin H. Kure, Paul M. Grandgenett, Michael A. Hollingsworth, Maria de Sousa, Sukhwinder Kaur, Maneesh Jain, Kavita Mallya, Surinder K. Batra, William R. Jarnagin, Mary S. Brady, Øystein Fodstad, Volkmar Muller, Klaus Pantel, Andy J. Minn, Mina J. Bissell, Benjamin A. García, Yibin Kang, Vinagolu K. Rajasekhar, Cyrus M. Ghajar, Irina Matei, Héctor Peinado, Jacqueline Bromberg, David Lyden - Nature 2015 cited by 5,185

  2. Mitotic progression following DNA damage enables pattern recognition within micronuclei

    Authors: , , , , , - Nature 2017 cited by 1,514

  3. Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade

    Authors: , , , , , , , , , , , , , , , , , , - Cell 2016 cited by 1,194

  4. Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Nature 2015 cited by 2,431

  5. Opposing Functions of Interferon Coordinate Adaptive and Innate Immune Responses to Cancer Immune Checkpoint Blockade

    Authors: , , , , , , , , , , , , , , , , - Cell 2019 cited by 563

  6. Design, Implementation, and in Vivo Validation of a Novel Proton FLASH Radiation Therapy System

    Authors: , , , , , , , , , , , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 2020 cited by 470

  7. Genes that mediate breast cancer metastasis to lung

    Authors: , , , , , , , , , - Nature 2005 cited by 2,975

  8. Combined JAK inhibition and PD-1 immunotherapy for non–small cell lung cancer patients

    Authors: , , , , , , , , , , , , , , , , , , , , , - Science 2024 cited by 207

  9. Genes that mediate breast cancer metastasis to the brain

    Authors: , , , , , , , , , , - Nature 2009 cited by 1,905

  10. Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies

    Authors: , - Immunity 2018 cited by 580

  11. An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer

    Authors: , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2008 cited by 622

  12. Exosome Transfer from Stromal to Breast Cancer Cells Regulates Therapy Resistance Pathways

    Authors: , , , , , , , , , , , , , - Cell 2014 cited by 804

  13. Nuclear Acetyl-CoA Production by ACLY Promotes Homologous Recombination

    Authors: , , , , , , , , , , , , , , - Molecular Cell 2017 cited by 291

  14. The immunostimulatory RNA RN7SL1 enables CAR-T cells to enhance autonomous and endogenous immune function

    Authors: , , , , , - Cell 2021 cited by 187

  15. Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Andy J. Minn, Martin L. Miller, Matthew D. Hellmann - Cancer Cell 2024 cited by 178

  16. Exosome RNA Unshielding Couples Stromal Activation to Pattern Recognition Receptor Signaling in Cancer

    Authors: , , , , , , , , , , - Cell 2017 cited by 457

  17. FLASH Proton Radiotherapy Spares Normal Epithelial and Mesenchymal Tissues While Preserving Sarcoma Response

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Cancer Research 2021 cited by 186

  18. Cancer cells resistant to immune checkpoint blockade acquire interferon-associated epigenetic memory to sustain T cell dysfunction

    Authors: , , , , , , , , , , , - Nature Cancer 2023 cited by 102

  19. High-Dimensional Variable Selection for Survival Data

    Authors: , , , , - Journal of the American Statistical Association 2010 cited by 454

  20. Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Derek A. Oldridge, Andy J. Minn, Christian U. Blank, Jeffrey S. Weber, Tara C. Mitchell, Michael D. Farwell, Ramin S. Herati, Alexander C. Huang - Cancer Cell 2024 cited by 96

  21. The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade

    Authors: , , , , , , , , , , , , , - Immunity 2022 cited by 91

  22. Combination Cancer Therapies with Immune Checkpoint Blockade: Convergence on Interferon Signaling

    Authors: , - Cell 2016 cited by 276

  23. Random survival forests for high-dimensional data

    Authors: , , , - Statistical Analysis and Data Mining The ASA Data Science Journal, Stat. Anal. Data Min. 2011 cited by 219

  24. Structure of Bcl-x L -Bak Peptide Complex: Recognition Between Regulators of Apoptosis

    Authors: , , , , , , , , , , , - Science 1997 cited by 1,463